Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells

This publication has 39 references indexed in Scilit:

• Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer
  Breast Cancer Research and Treatment, 1984
• LHRH-agonist treatment in metastatic prostate carcinoma
  European Journal of Cancer and Clinical Oncology, 1984
• CLINICAL APPLICATIONS OF LHRH AND ITS ANALOGUES
  Clinical Endocrinology, 1983
• SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA
  The Lancet, 1982
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Sertoli–Leydig cell communication via an LHRH-like factor
  Nature, 1981
• Recent Approaches to Fertility Control Based on Derivatives of LH-RH
  Published by Elsevier ,1981
• Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production
  Nature, 1979
• Extrapituitary Action of Gonadotropin-Releasing Hormone: Direct Inhibition Ovarian Steroidogenesis
  Science, 1979
• SUPPRESSION OF GONADOTROPHIN RELEASE IN MAN BY AN INHIBITORY ANALOGUE OF L.H.-RELEASING HORMONE
  The Lancet, 1977